Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Hypercalcemia of Malignancy|Metastatic Cancer
Interventions: DRUG: ibandronate sodium|DRUG: zoledronic acid|DRUG: Zolendronic Acid
Sponsor: Wales Cancer Trials Unit
Collaborators: Velindre NHS Trust